Search results
Moderna wins COVID shot patent case against Pfizer-BioNTech in Europe
Reuters via AOL· 7 days agoThe company has been locked in a legal battle with Pfizer-BioNTech over their COVID shot Comirnaty...
Selling US$3.3m Of Moderna Stock Rewarded Insiders
Simply Wall St. via Yahoo Finance· 3 days agoModerna, Inc.'s (NASDAQ:MRNA) stock rose 12% last week, but insiders who sold US$3.3m worth of stock over the last year are probably in a more...
Biotech stocks are rising alongside bird flu fears
Semafor via Yahoo Finance· 10 hours agoVaccine makers, including Moderna, BioNTech, and CureVac, all saw double-digit stock increases, as investors bet they could cash in on a public health...
Robeco Institutional Asset Management B.V. Decreases Stake in Moderna, Inc. (NASDAQ:MRNA)
ETF DAILY NEWS· 3 days agoRobeco Institutional Asset Management B.V. lowered its position in Moderna, Inc. (NASDAQ:MRNA – Free Report) by 51.1% in the 4th quarter, according to the company in its most ...
Moderna Announces Data to be Presented at 2024 ASCO Annual Meeting
The Sacramento Bee· 2 days agoModerna to host an investor event via webcast on Monday, June 3 at 6:15 PM CDT
Moderna’s Push to Personalize Cancer Treatments
Bloomberg· 3 days agoHi, it’s Gerry in New York. I recently toured Moderna’s manufacturing facility to see how they make personalized cancer vaccines. But first ...
Could Novavax Become the Next Moderna? | The Motley Fool
The Motley Fool· 7 days agoNovavax (NVAX -9.65%) and Moderna (MRNA 0.17%) both entered the coronavirus vaccine race around the...
Bird Flu Cases Spur Retail Trader Rush Into Vaccine Stocks
Bloomberg via Yahoo Finance· 1 day ago(Bloomberg) -- Mounting cases of bird flu in humans is luring the day trading crowd to snap up stock...
Vaccine makers receive stock boost after third human bird flu case in US
Newsweek· 15 hours agoShares in some companies that produce vaccines have seen stock boosts following a small number of...
Moderna and Novavax Hope for Early Launch of This Year’s Covid-19 Shots
Barrons.com· 3 days agoAfter disappointing sales for their Covid vaccines last year, Moderna, Novavax, and Pfizer are...